$3.20
0.26.67%
Pre-Market: 5:34 PM EDT
15 minutes delayed
SAB Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of SAB Biotherapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-0.79 | $-1.03 | 23.3 % |
Mar 2024 | 2024-05-20 | $-0.54 | $-0.46 | -17.4 % |
Dec 2023 | 2024-03-29 | $-3.84 | $-0.62 | -519.4 % |
Sep 2023 | 2023-11-13 | $-1.00 | $-1.20 | 16.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2023 | 2023-11-13 | $1.27M | $20.00K | 6235.0 % |
Mar 2023 | 2023-05-16 | $581.10K | $2.36M | -75.4 % |
Mar 2023 | 2023-04-14 | $2.16M | $6.50M | -66.8 % |
Sep 2022 | 2022-11-15 | $3.59M | $6.85M | -47.6 % |
SAB Biotherapeutics (SABS) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-0.79, which beat the estimate of $-1.03.
The Actual Revenue was $263.1K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.